Due to the small sample size, the current study cannot confirm if the serum TCF7L2 gene expression might have a predictive value regarding postoperative weight loss and/or T2DM remission in patients undergoing bariatric surgery. This evidence concerns the gene TCF7L2 and type 2 diabetes mellitus.